(NYSE: STE) Steris's forecast annual revenue growth rate of 5.32% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 9.07%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.5%.
Steris's revenue in 2026 is $5,828,131,000.On average, 11 Wall Street analysts forecast STE's revenue for 2026 to be $588,352,074,975, with the lowest STE revenue forecast at $569,717,820,225, and the highest STE revenue forecast at $612,772,756,200. On average, 11 Wall Street analysts forecast STE's revenue for 2027 to be $625,522,509,450, with the lowest STE revenue forecast at $596,100,001,950, and the highest STE revenue forecast at $657,102,667,500.
In 2028, STE is forecast to generate $669,165,895,575 in revenue, with the lowest revenue forecast at $644,352,914,250 and the highest revenue forecast at $707,317,080,300.